Related Experiment Video

Updated: Aug 17, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease

Gjin Ndrepepa1, Siegmund Braun, Nicolas von Beckerath

  • 1Klinik für Herz-und Kreislauferkrankungen, Deutsches Herzzentrum München, Germany. ndrepepa@dhm.mhn.de

Clinica Chimica Acta; International Journal of Clinical Chemistry
|July 5, 2005
PubMed

Insights

Statin therapy lowers oxidized low-density lipoproteins (OxLDL) in coronary artery disease (CAD) patients. Statins also weaken the link between OxLDL levels and CAD severity.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • The relationship between oxidized low-density lipoproteins (OxLDL) and coronary artery disease (CAD) severity is not fully understood, especially concerning the influence of statin therapy.
  • Previous research has not investigated how statin use affects OxLDL levels and their association with CAD severity.

Purpose of the Study:

  • To investigate the impact of statin therapy on circulating OxLDL levels.
  • To determine the association between OxLDL levels and the severity of coronary artery disease (CAD).
  • To explore the interaction between statin therapy and OxLDL in relation to CAD severity.

Main Methods:

  • Oxidized low-density lipoproteins (OxLDL) were quantified using Enzyme-Linked Immunosorbent Assay (ELISA) in 687 patients with angiographically proven CAD.
  • Patient groups were stratified based on statin therapy status (on statins vs. not on statins).
  • Statistical analyses, including multivariable analysis and logistic regression, were employed to assess predictors and correlates of OxLDL levels and CAD severity.

Main Results:

  • Patients on statin therapy exhibited significantly lower OxLDL levels compared to those not on statins (P<0.001).
  • Statin therapy was identified as an independent predictor of reduced OxLDL levels (P=0.0001).
  • Oxidized low-density lipoproteins (OxLDL) were found to be an independent correlate of angiographic CAD severity (P=0.04), with a significant interaction (P=0.038) indicating that statins attenuate the association between higher OxLDL and more extensive CAD.

Conclusions:

  • Statin therapy is associated with lower circulating OxLDL levels in patients with CAD.
  • Statin use attenuates the relationship between elevated OxLDL levels and the severity of coronary artery disease.
  • These findings highlight a potential mechanism by which statins exert their cardioprotective effects.
Abstract

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...